These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 12721952)

  • 1. Detection of attenuated, noninfectious spirochetes in Borrelia burgdorferi-infected mice, after antibiotic treatment.
    Liegner KB
    J Infect Dis; 2003 May; 187(10):1676; author reply 1676. PubMed ID: 12721952
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of attenuated, noninfectious spirochetes in Borrelia burgdorferi-infected mice after antibiotic treatment.
    Bockenstedt LK; Mao J; Hodzic E; Barthold SW; Fish D
    J Infect Dis; 2002 Nov; 186(10):1430-7. PubMed ID: 12404158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-tumor necrosis factor-alpha treatment activates Borrelia burgdorferi spirochetes 4 weeks after ceftriaxone treatment in C3H/He mice.
    Yrjänäinen H; Hytönen J; Song XY; Oksi J; Hartiala K; Viljanen MK
    J Infect Dis; 2007 May; 195(10):1489-96. PubMed ID: 17436229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-tumor necrosis factor-alpha activation of Borrelia burgdorferi spirochetes in antibiotic-treated murine Lyme borreliosis: an unproven conclusion.
    Wormser GP; Barthold SW; Shapiro ED; Dattwyler RJ; Bakken JS; Steere AC; Bockenstedt LK; Radolf JD
    J Infect Dis; 2007 Dec; 196(12):1865-6; author reply 1866-7. PubMed ID: 18190269
    [No Abstract]   [Full Text] [Related]  

  • 5. Persistence of borrelial DNA in the joints of Borrelia burgdorferi-infected mice after ceftriaxone treatment.
    Yrjänäinen H; Hytönen J; Hartiala P; Oksi J; Viljanen MK
    APMIS; 2010 Sep; 118(9):665-73. PubMed ID: 20718718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent Borrelia burgdorferi infection after treatment with antibiotics and anti-tumor necrosis factor-alpha.
    Stricker RB; Johnson L
    J Infect Dis; 2008 May; 197(9):1352-3. PubMed ID: 18422450
    [No Abstract]   [Full Text] [Related]  

  • 7. A doxycycline hyclate rodent bait formulation for prophylaxis and treatment of tick-transmitted Borrelia burgdorferi.
    Dolan MC; Zeidner NS; Gabitzsch E; Dietrich G; Borchert JN; Poché RM; Piesman J
    Am J Trop Med Hyg; 2008 May; 78(5):803-5. PubMed ID: 18458316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coinfection with Borrelia burgdorferi sensu stricto and Borrelia garinii alters the course of murine Lyme borreliosis.
    Hovius JW; Li X; Ramamoorthi N; van Dam AP; Barthold SW; van der Poll T; Speelman P; Fikrig E
    FEMS Immunol Med Microbiol; 2007 Mar; 49(2):224-34. PubMed ID: 17328756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lyme Borreliosis: Is there a preexisting (natural) variation in antimicrobial susceptibility among Borrelia burgdorferi strains?
    Hodzic E
    Bosn J Basic Med Sci; 2015 Jul; 15(3):1-13. PubMed ID: 26295288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistence of Borrelia burgdorferi in rhesus macaques following antibiotic treatment of disseminated infection.
    Embers ME; Barthold SW; Borda JT; Bowers L; Doyle L; Hodzic E; Jacobs MB; Hasenkampf NR; Martin DS; Narasimhan S; Phillippi-Falkenstein KM; Purcell JE; Ratterree MS; Philipp MT
    PLoS One; 2012; 7(1):e29914. PubMed ID: 22253822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Status of Borrelia burgdorferi infection after antibiotic treatment and the effects of corticosteroids: An experimental study.
    Straubinger RK; Straubinger AF; Summers BA; Jacobson RH
    J Infect Dis; 2000 Mar; 181(3):1069-81. PubMed ID: 10720533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Borrelia burgdorferi--a unique bacterium].
    Brorson Ø
    Tidsskr Nor Laegeforen; 2009 Oct; 129(20):2114-7. PubMed ID: 19855450
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibiotic treatment of experimentally Borrelia burgdorferi-infected ponies.
    Chang YF; Ku YW; Chang CF; Chang CD; McDonough SP; Divers T; Pough M; Torres A
    Vet Microbiol; 2005 May; 107(3-4):285-94. PubMed ID: 15863289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of an evernimicin (SCH27899) in vitro and in an animal model of Lyme disease.
    Pavia CS; Wormser GP; Nowakowski J; Cacciapuoti A
    Antimicrob Agents Chemother; 2001 Mar; 45(3):936-7. PubMed ID: 11181384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Radiculalgia revealing Lyme disease].
    Chekili S; Laatar A; Kassab S; Ben Abdelghani K; Marhoul LR; Zakraoui L
    Tunis Med; 2008 Nov; 86(11):1023. PubMed ID: 19213505
    [No Abstract]   [Full Text] [Related]  

  • 16. Counterpoint: long-term antibiotic therapy improves persistent symptoms associated with lyme disease.
    Stricker RB
    Clin Infect Dis; 2007 Jul; 45(2):149-57. PubMed ID: 17578772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lyme myositis.
    Holmgren AR; Matteson EL
    Arthritis Rheum; 2006 Aug; 54(8):2697-700. PubMed ID: 16871548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lyme arthritis].
    Rydz-Stryszowska I; Batko B; Krawiec P; Krzanowski M; Jurek-Krawiec M; Skura A
    Przegl Lek; 2007; 64(2):111-4. PubMed ID: 17892043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy for Lyme arthritis: strategies for the treatment of antibiotic-refractory arthritis.
    Steere AC; Angelis SM
    Arthritis Rheum; 2006 Oct; 54(10):3079-86. PubMed ID: 17009226
    [No Abstract]   [Full Text] [Related]  

  • 20. Bradycardic child: what's to blame?
    Kline AM
    J Pediatr Health Care; 2007; 21(6):399-400. PubMed ID: 17980807
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.